Literature DB >> 1414248

Early onset MS under the age of 16: clinical and paraclinical features.

E Sindern1, J Haas, E Stark, U Wurster.   

Abstract

MS in juvenile patients under the age of 16 occurred in 31 (5%) of our whole MS population of 620 patients in the time from 1975-1991. It does not differ clinically from the disease as observed in 72 patients with later onset MS in respect to symptoms at onset, course, progression rate, rate of relapses and abnormalities in CSF and MRI. However, fever, headache, nausea and vomiting with pleocytosis in CSF during the first episode and development of oligoclonal bands with passage of time may be characteristic in some juvenile patients. The presence of oligoclonal bands and MRI results are of high diagnostic value in this special group of patients.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1414248     DOI: 10.1111/j.1600-0404.1992.tb05086.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  29 in total

1.  The course of early-onset multiple sclerosis in Iraqi children.

Authors:  Hasan A Al-Hamadani; Atheer S Abdalla; Atheer J Al-Saffar
Journal:  World J Pediatr       Date:  2011-06-01       Impact factor: 2.764

2.  Primary CNS demyelinating diseases in childhood: multiple sclerosis.

Authors:  P Iannetti; M G Marciani; A Spalice; F Spanedda; U Raucci; G Trasimeni; G F Gualdi; G Bernardi
Journal:  Childs Nerv Syst       Date:  1996-03       Impact factor: 1.475

3.  Clinical characteristics and long term prognosis in early onset multiple sclerosis.

Authors:  Olivier Deryck; Pierre Ketelaer; Bénédicte Dubois
Journal:  J Neurol       Date:  2006-03-06       Impact factor: 4.849

4.  Paediatric multiple sclerosis and acute disseminated encephalomyelitis in Germany: results of a nationwide survey.

Authors:  Daniela Pohl; Isabell Hennemuth; Rüdiger von Kries; Folker Hanefeld
Journal:  Eur J Pediatr       Date:  2007-01-12       Impact factor: 3.183

5.  Is a preserved functional reserve a mechanism limiting clinical impairment in pediatric MS patients?

Authors:  Maria A Rocca; Martina Absinta; Angelo Ghezzi; Lucia Moiola; Giancarlo Comi; Massimo Filippi
Journal:  Hum Brain Mapp       Date:  2009-09       Impact factor: 5.038

6.  Characteristics of Children and Adolescents With Multiple Sclerosis.

Authors:  Anita L Belman; Lauren B Krupp; Cody S Olsen; John W Rose; Greg Aaen; Leslie Benson; Tanuja Chitnis; Mark Gorman; Jennifer Graves; Yolander Harris; Tim Lotze; Jayne Ness; Moses Rodriguez; Jan-Mendelt Tillema; Emmanuelle Waubant; Bianca Weinstock-Guttman; T Charles Casper
Journal:  Pediatrics       Date:  2016-07       Impact factor: 7.124

Review 7.  Pediatric multiple sclerosis.

Authors:  E Ann Yeh; Tanuja Chitnis; Lauren Krupp; Jayne Ness; Dorothée Chabas; Nancy Kuntz; Emmanuelle Waubant
Journal:  Nat Rev Neurol       Date:  2009-10-13       Impact factor: 42.937

8.  Visually induced paroxysmal nausea and vomiting as presenting manifestations of multiple sclerosis.

Authors:  O A Khan; G M Sandoz; M J Olek; A J Kuta
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-09       Impact factor: 10.154

9.  Pediatric multiple sclerosis.

Authors:  Yashma Patel; Vikram Bhise; Lauren Krupp
Journal:  Ann Indian Acad Neurol       Date:  2009-10       Impact factor: 1.383

Review 10.  Disease-modifying therapy of pediatric multiple sclerosis.

Authors:  Tanuja Chitnis
Journal:  Neurotherapeutics       Date:  2013-01       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.